Table 2 Identification of HEV serotypes using microarray, de novo sequencing, and in silico model of de novo sequence results.
Strain | VP1 typing# | Array | de novo sequence | in silico model | Accession number |
|---|---|---|---|---|---|
1 | CAVA16 | CAVA16 | ND | ND | Â |
2 | EV71 | EV71 | ND | ND | Â |
3 | CAVA21 | CAVA21 | ND | ND | Â |
4 | CAVB4 | CAVB4 | ND | ND | Â |
5 | EV3 | EV3 | EV3(95%) | CAV16 | EU870485 |
6 | EV68 | EV68 | EV68(99%) | EV68 | EU870491 |
7 | EV69 | EV69 | ND | ND | Â |
8 | EV70 | EV70 | ND | ND | Â |
9 | EV75 | EV75 | EV75(99%) | EV75 | EU870493 |
10 | EV4 | EV6 | EV6(93%) | EV4 | EU870488 |
11 | EV5 | CAVB3 | CAVB3(94%) | CAVB3 | EU870489 |
12 | EV30 | HEVB | EV30(95%) | EV30 | EU870486 |
13 | CAVA14 | HEVA/B | ND | ND | Â |
14 | EV1 | HEVB | ND | ND | Â |
15 | EV6 | HEVB | EV74(94%) | HEVB | EU870490 |
16 | EV7 | HEVB | EV30(95%) | HEVB | EU870492 |
17 | EV11 | HEVB | ND | ND | Â |
18 | EV18 | HEVB | EV74(93%) | HEVB | EU870483 |
29 | EV29 | HEVB | EV80(85%) | HEVB | EU870484 |
20 | CAVA20 | HEVC | ND | ND | Â |
21 | CAVA24 | HEVC | ND | ND | Â |
22 | CAVA9 | HEVB | ND | ND | Â |
23 | CAVB1 | HEVB | ND | ND | Â |
24 | CAVB2 | HEVB | ND | ND | Â |
25 | CAVB3 | HEVB | ND | ND | Â |
26 | EV25 | HEVB | ND | ND | Â |
27 | EV33 | HEVB | CAVA12(91%) | HEVB | EU870487 |
28 | EV9 | HEVB | ND | ND | Â |